deltatrials
Active Not Recruiting OBSERVATIONAL NCT03199300

Investigating Cardiovascular Adverse Events Related to Cancer Treatment (InvestiCAT)

Investigating Cardiovascular Adverse Events Related to Cancer Treatment: a Study of Extreme Toxicity Using Induced Pluripotent Stem Cells

Sponsor: University Medical Center Groningen

Conditions Cancer, Treatment-Related Cardiovascular Morbidity Toxicity Due to Chemotherapy
Interventions Anthracyclines Bleomycin Cisplatin Trastuzumab
Updated 19 times since 2017 Last updated: Dec 4, 2025 Started: Dec 12, 2017 Primary completion: Feb 6, 2025 Completion: Jan 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Cancer, Treatment-Related and Cardiovascular Morbidity, this trial is ongoing. The trial is conducted by University Medical Center Groningen and has accumulated 19 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jun 2019 · 6 months · monthly snapshot~Jun 2019 – ~Jul 2020 · 13 months · monthly snapshot~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Dec 2021 · 9 months · monthly snapshot~Dec 2021 – ~Sep 2022 · 9 months · monthly snapshot~Sep 2022 – ~Dec 2023 · 15 months · monthly snapshot~Dec 2023 – ~Jun 2024 · 6 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshot~Oct 2025 – ~Jan 2026 · 3 months · monthly snapshot~Jan 2026 – present · 8 months · monthly snapshot

Change History

19 versions recorded

  1. Jan 2026 — Present [monthly]

    Active Not Recruiting

  2. Oct 2025 — Jan 2026 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  3. Sep 2024 — Oct 2025 [monthly]

    Recruiting

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  5. Jun 2024 — Jul 2024 [monthly]

    Recruiting

▶ Show 14 earlier versions

  1. Dec 2023 — Jun 2024 [monthly]

    Recruiting

  2. Sep 2022 — Dec 2023 [monthly]

    Recruiting

  3. Dec 2021 — Sep 2022 [monthly]

    Recruiting

  4. Mar 2021 — Dec 2021 [monthly]

    Recruiting

  5. Jan 2021 — Mar 2021 [monthly]

    Recruiting

  6. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  7. Jul 2020 — Nov 2020 [monthly]

    Recruiting

  8. Jun 2019 — Jul 2020 [monthly]

    Recruiting

  9. Dec 2018 — Jun 2019 [monthly]

    Recruiting

  10. Jun 2018 — Dec 2018 [monthly]

    Recruiting

  11. May 2018 — Jun 2018 [monthly]

    Recruiting

  12. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  13. Dec 2017 — Apr 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  14. Aug 2017 — Dec 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University Medical Center Groningen
Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations